EP0223410A3 - Ethanolaminderivate - Google Patents

Ethanolaminderivate Download PDF

Info

Publication number
EP0223410A3
EP0223410A3 EP86307981A EP86307981A EP0223410A3 EP 0223410 A3 EP0223410 A3 EP 0223410A3 EP 86307981 A EP86307981 A EP 86307981A EP 86307981 A EP86307981 A EP 86307981A EP 0223410 A3 EP0223410 A3 EP 0223410A3
Authority
EP
European Patent Office
Prior art keywords
group
alkyl
hydrogen atom
alkoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86307981A
Other languages
English (en)
French (fr)
Other versions
EP0223410A2 (de
Inventor
Harry Finch
Lawrence Henry Charles Lunts
Alan Naylor
Ian Frederick Skidmore
Ian Baxter Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525488A external-priority patent/GB8525488D0/en
Priority claimed from GB858525489A external-priority patent/GB8525489D0/en
Priority claimed from GB858525491A external-priority patent/GB8525491D0/en
Priority claimed from GB858525490A external-priority patent/GB8525490D0/en
Priority claimed from GB858525492A external-priority patent/GB8525492D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of EP0223410A2 publication Critical patent/EP0223410A2/de
Publication of EP0223410A3 publication Critical patent/EP0223410A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP86307981A 1985-10-16 1986-10-15 Ethanolaminderivate Withdrawn EP0223410A3 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB8525488 1985-10-16
GB858525488A GB8525488D0 (en) 1985-10-16 1985-10-16 Chemical compounds
GB8525492 1985-10-16
GB858525489A GB8525489D0 (en) 1985-10-16 1985-10-16 Chemical compounds
GB858525491A GB8525491D0 (en) 1985-10-16 1985-10-16 Chemical compounds
GB8525491 1985-10-16
GB8525489 1985-10-16
GB8525490 1985-10-16
GB858525490A GB8525490D0 (en) 1985-10-16 1985-10-16 Chemical compounds
GB858525492A GB8525492D0 (en) 1985-10-16 1985-10-16 Chemical compounds

Publications (2)

Publication Number Publication Date
EP0223410A2 EP0223410A2 (de) 1987-05-27
EP0223410A3 true EP0223410A3 (de) 1987-11-19

Family

ID=27516620

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86307981A Withdrawn EP0223410A3 (de) 1985-10-16 1986-10-15 Ethanolaminderivate

Country Status (1)

Country Link
EP (1) EP0223410A3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718938D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
GB8718940D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
ES2039646T3 (es) * 1987-11-13 1993-10-01 Glaxo Group Limited Derivados de fenetanolamina.
ZA889405B (en) * 1987-12-18 1989-12-27 Glaxo Group Ltd Ethanolamine derivatives
NZ227365A (en) * 1987-12-18 1990-10-26 Glaxo Group Ltd Aromatic amino ethers and pharmaceutical compositions
GB8909273D0 (en) * 1989-04-24 1989-06-07 Glaxo Group Ltd Chemical compounds
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
WO2002070490A1 (en) 2001-03-08 2002-09-12 Glaxo Group Limited Agonists of beta-adrenoceptors
WO2002076933A1 (en) 2001-03-22 2002-10-03 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
ES2438985T3 (es) 2001-09-14 2014-01-21 Glaxo Group Limited Formulación de inhalación que comprende derivados de fenetanolamina para el tratamiento de enfermedades respiratorias
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545482A1 (fr) * 1983-04-18 1984-11-09 Glaxo Group Ltd Derives de phenethanolamine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545482A1 (fr) * 1983-04-18 1984-11-09 Glaxo Group Ltd Derives de phenethanolamine

Also Published As

Publication number Publication date
EP0223410A2 (de) 1987-05-27

Similar Documents

Publication Publication Date Title
EP0220054A3 (de) Ethanolaminderivate
ATE39350T1 (de) Aminophenolderivate.
DE68906552T2 (de) Camptothecin-Derivate und Verfahren zu ihrer Herstellung.
EP0220878A3 (de) Ethanolaminverbindungen
MY102087A (en) Phenethanolamine derivatives.
EP0223410A3 (de) Ethanolaminderivate
FI965020A0 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
AU584929B2 (en) Dichloroaniline derivatives
ATE113940T1 (de) Aminobenzolsulfonsäurederivate.
EP0215297A3 (de) Substituierte Dipeptidamide
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
EP0315434A3 (de) Pyridoxalhydrazon-Derivate, ihre Herstellung und Verwendung und diese enthaltende Arzneimittel
EP0198633A3 (de) Pyridinderivate
EP0219350A3 (de) Ethanolaminverbindungen
ES557637A0 (es) Un procedimiento para preparar nuevos derivados de (4.2.0) biciclooctano.
EP0303466A3 (de) Ethanolamin-Derivate
EP0278727A3 (de) 1-(4-Amino-3-chloro-5-trifluoromethylphenyl)-2-(substituierte amino)ethanol-Derivate und ihre Verwendung bei der Behandlung von Lungenkrankheiten
EP0278728A3 (de) 1-(4-Amino-3,5-dichlorophenyl)-2-(substituierte amino)ethanol-Derivate und ihre Verwendung für die Behandlung von Lungenkrankheiten
MY104048A (en) New allylaminoethylazoles.
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
EP0197664A3 (de) 2-Aminopyrimidinonderivate
EP0050916A3 (de) ZNS-Stimulanzien und antihypertensive Mittel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19880315

17Q First examination report despatched

Effective date: 19890628

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19910607

R18W Application withdrawn (corrected)

Effective date: 19910607

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SKIDMORE, IAN FREDERICK

Inventor name: LUNTS, LAWRENCE HENRY CHARLES

Inventor name: FINCH, HARRY

Inventor name: CAMPBELL, IAN BAXTER

Inventor name: NAYLOR, ALAN